CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

Developer NexCore Group Partners with Cushman & Wakefield on Waterway Labs at 16 Tech in Indianapolis

Bailey Webb • 12/11/2023
Cushman & Wakefield leasing NexCore’s 100,000-SF purpose-built development to support growth of Indiana life sciences startups and companies 

INDIANAPOLIS, December 11, 2023 – NexCore Group has announced plans to develop Waterway Labs at 16 Tech in Indianapolis, with Cushman & Wakefield providing agency leasing services for the $60 million development, a purpose-built life sciences lab building offering graduation lab space for growing companies. 

Denver-based NexCore anticipates breaking ground in 2024 on the 100,000-square-foot life-sciences focused lab building at 1206 Waterway Blvd. within the 16 Tech Innovation District. 16 Tech is a 50-acre destination for entrepreneurship and innovation, located adjacent to the future campuses of Indiana University Indianapolis and Purdue University in Indanapolis. Opened in 2020, 16 Tech is intentionally resourced with the facilities and programs to support innovation-driven entrepreneurship and applied research opportuntities. The district boasts more than 200+ innovation related entitites, including a growing cluster of startups in life sciences, health tech and med tech industries as well as the resources to facilitate the prototyping and development of physical products in a variety of industries and at industrial scale. 16 Tech anchor tenants include the Indiana Biosciences Research Institute, a leading translational research institute with capabilities in diabetes, Alzheimers and pediatric rare disease research, and the Emerging Manufacturing Collaboration Center with strengths in autonomous vehicle technology, Industry 4.0 implementation and additive manufacturing.  

Recognizing the robust infrastructure in Indiana, the U.S. Department of Commerce recently designated Indiana as a tech hub, with a winning application submitted by Heartland BioWorks, a consortium of state entities that includes 16 Tech, colleges and universities, industry groups and some of the state’s largest employers. In addition, 16 Tech was recently named a spoke of the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub based in Boston, another indicator of the resources available to support commercialization of health innovation.  

“We’re fortunate to have an incredible foundation for Waterway Labs,” said Allan Glass, NexCore Executive Vice President, Life Sciences. “Indiana’s and Indianapolis’s world-renowned R-1 research institutions, health systems, base of life sciences and pharma companies and growing startup ecosystem, as well as forward-thinking economic development at the local and state level, all create the perfect atmosphere for a purpose-built life science development focused on startups graduating out of academic labs and incubation environments.”  

“Waterway Labs will take a leading position in providing ‘graduation’ space for growing companies emerging from our research universities as well as other startups and established firms,” said Jon Owens, Cushman & Wakefield Managing Director. “What’s more, Waterway Labs’ tenants will be a perfect complement to 16 Tech and the dynamic Life Science environment that’s developing in Central Indiana and across the state.” 

Owens and Cushman & Wakefield’s Joshua Graham will lead leasing for Waterway Labs. The five-story development will include two types of space as part of NexCore’s HATCHspaces operating platform: HATCHlabs and HATCHx.  

HATCHlabs will include four levels with 22,000-square-foot floorplates, featuring: warm shell lab enabled space, purpose-built for tenants needing to design their optimal suite layout with long-term leases; support for BSL-1 and BSL-2 level labs; 16-foot floor-to-floor/15-foot 6-inches clear height; 100 PSF live floor loading and 20 PSF dead load; floor vibration criteria of 6,000 mips; 20 watts/RSF of electrical capacity; 274-watt diesel emergency generator; 100% outside air with six-air changes per hour; break and lounge areas; common restrooms; and common chemical waste storage room.  

The HATCHx floor will offer eight turnkey lab suites of 2,000 square feet plus 10 offices in a co-working environment, where tenants can lease single lab suites and single office suites based on their space needs. Features include turn-key, fully furnished lab suites supporting BSL-1 and BSL-2 level labs; common freezer farm; and shared conference room. 

About NexCore Group LLC 
NexCore Group is a national healthcare real estate investment and development company that focuses on acquiring, developing, owning, and managing purpose-built facilities for healthcare, science and technology, and senior living. Since its founding in 2004, NexCore has successfully completed over $5.7 billion in real estate transactions throughout 29 states, developed and acquired over 16 million square feet of healthcare, science, and senior living communities, and currently manages over $3.3 billion in assets spanning 7.6 million square feet. NexCore is headquartered in Denver, with regional offices in Bethesda, Charlotte, Dallas, Detroit, Houston, Indianapolis, Los Angeles, Orlando, Phoenix, and Seattle. 
About Cushman & Wakefield
Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In 2023, the firm reported revenue of $9.5 billion across its core services of property, facilities and project management, leasing, capital markets, and valuation and other services. It also receives numerous industry and business accolades for its award-winning culture and commitment to Diversity, Equity and Inclusion (DEI), sustainability and more. For additional information, visit www.cushmanwakefield.com.

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on  Cookies

More Options
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS